CDKN2A and central nervous system cancer: NF1-associated gliomas in the molecular high-grade group often had increased cellular density, higher Ki-67 labeling indices, and loss of p16 and/or ATRX expression on immunohistochemical evaluation compared to the molecular low-grade group.